In Re Zostavax (Zoster Vaccine Live) Products Liability Litigation

Whenever there is the prospect of a large litigation involving significant numbers of plaintiffs, the question of whether to move for a multi-district litigation (MDL) invariably arises. On the one hand, MDLs can provide a useful process to streamline pretrial proceedings before a single judge in one court, ensuring consistent application of law and coordination in discovery and motion practice. On the other, MDLs can encourage the filing of significant numbers of cases with […]

By | September 18th, 2025 ||

CPSC Maintains Momentum On EFiling Requirements For Consumer Products

A question often asked by consumer product companies these days is whether the eFiling requirements will go into effect as planned given the political upheaval at the U.S. Consumer Product Safety Commission (CPSC) and the dismissal of the three Democrat Commissioners. While that is an impossible question to answer with certainty, all signals suggest the requirements will be implemented on schedule for July 8, 2026.

On December 18, 2024, the CPSC―with a then-full roster of […]

By | September 14th, 2025 ||

PFAS Update: States Continue To Be Out Front On PFAS In Products Restrictions

Per- and polyfluoroalkyl substances (PFAS), often dubbed “forever chemicals,” continue to be a major focus of environmental regulation across the United States. At least 10 states have enacted prohibitions on sales of certain products containing PFAS, such as in carpets and rugs and personal care products. Several states have enacted very broad prohibitions affecting a substantial number of consumer use product categories; New Mexico is the most recent to join the ranks of a […]

By | September 12th, 2025 ||